We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00215852
Recruitment Status : Terminated
First Posted : September 22, 2005
Last Update Posted : September 4, 2013
Sponsor:
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2009
  Study Completion Date : April 2009
  Certification or Request for Extension to Delay Results Submission: August 27, 2013